🇺🇸 FDA
Patent

US 10738010

Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides

granted A61PA61P19/00A61P27/02

Quick answer

US patent 10738010 (Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides) held by Akebia Therapeutics, Inc. expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Akebia Therapeutics, Inc.
Grant date
Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P19/00, A61P27/02, A61P35/00, A61P43/00